Astria Therapeutics, Inc.
ATXS
$7.49
-$0.04-0.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 259.18M | 295.06M | 328.13M | 344.28M | 354.70M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.41M | 7.90M | 6.51M | 7.58M | 3.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 163.00K |
| Total Current Assets | 268.59M | 302.97M | 334.64M | 351.86M | 357.89M |
|
|
|||||
| Total Current Assets | 268.59M | 302.97M | 334.64M | 351.86M | 357.89M |
| Net Property, Plant & Equipment | 4.55M | 4.83M | 5.11M | 5.39M | 5.72M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.79M | 2.59M | 2.61M | 4.39M | 4.39M |
| Total Assets | 281.92M | 310.39M | 342.36M | 361.64M | 367.99M |
|
|
|||||
| Total Accounts Payable | 738.00K | 3.70M | 4.32M | 1.28M | 2.34M |
| Total Accrued Expenses | 15.91M | 12.34M | 13.43M | 13.07M | 12.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.40M | 1.39M | 1.38M | 1.38M | 1.25M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 18.04M | 17.43M | 19.13M | 15.72M | 16.37M |
|
|
|||||
| Total Current Liabilities | 18.04M | 17.43M | 19.13M | 15.72M | 16.37M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.37M | 3.67M | 3.97M | 4.26M | 4.54M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.41M | 21.10M | 23.10M | 19.99M | 20.91M |
|
|
|||||
| Common Stock & APIC | 906.76M | 902.41M | 898.57M | 895.17M | 876.43M |
| Retained Earnings | -741.56M | -708.50M | -674.79M | -649.17M | -624.63M |
| Treasury Stock & Other | -16.00K | 60.00K | 163.00K | 331.00K | -45.00K |
| Total Common Equity | 165.19M | 193.97M | 223.94M | 246.33M | 251.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 95.32M | 95.32M | 95.32M | 95.32M | 95.32M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 95.32M | 95.32M | 95.32M | 95.32M | 95.32M |
|
|
|||||
| Total Common Equity | 165.19M | 193.97M | 223.94M | 246.33M | 251.75M |
| Total Preferred Equity | 95.32M | 95.32M | 95.32M | 95.32M | 95.32M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 260.51M | 289.29M | 319.26M | 341.65M | 347.08M |
|
|
|||||